
Please try another search
Investing.com - Core Laboratories (NYSE: CLB) reported first quarter EPS of $0.19, $0.03 better than the analyst estimate of $0.16. Revenue for the quarter came in at $128M versus the consensus...
By Davit Kirakosyan Investing.com -- Here is your daily Pro Recap of the biggest analyst cuts you may have missed since yesterday: Downgrades for Rivian and Algonquin, plus three more slashed...
Core Laboratories (CLB) reported Q4 EPS of $0.14, $0.05 worse than the analyst estimate of $0.19. Revenue for the quarter came in at $127.58 million versus the consensus estimate of $130.03 million.
Investing.com - Core Laboratories (NYSE: CLB) reported fourth quarter EPS of $0.14, $0.05 worse than the analyst estimate of $0.19. Revenue for the quarter came in at $127.58M versus the consensus...
By Marianna Parraga and Jonathan Saul HOUSTON/LONDON (Reuters) - When the supertanker Young Yong sailed to the Chinese port of Qingdao in September last year, it had quality certificates for its...
Core Laboratories (CLB) reported Q3 EPS of $0.18, $0.03 better than the analyst estimate of $0.15. Revenue for the quarter came in at $126 million versus the consensus estimate of $125.97...
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review